High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$110K
$110,333
Total Sells (Filtered)
$1.7M
$1,654,461
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| CAI |
Caris Life Sciences, Inc.
|
Director
Other
|
2026-01-09 | $46,500 | M | Form 4 |
|
CAI
M
Caris Life Sciences, Inc.
Power Luke Thomas
• Officer • See Remarks
Equity Compensation
2025-12-11
$151,890x4
|
||||||
| CAI |
Caris Life Sciences, Inc.
|
Officer • See Remarks
Equity Compensation
|
2025-12-11 | $151,890x4 | M | Form 4 |
|
CAI
S
Caris Life Sciences, Inc.
Power Luke Thomas
• Officer • See Remarks
10b5-1 Sell
2025-12-11
$1,654,461Largex2
|
||||||
| CAI |
Caris Life Sciences, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-12-11 | $1,654,461Largex2 | S | Form 4 |
|
CAI
P
Caris Life Sciences, Inc.
Denton John Russel
• Officer • See Remarks
Discretionary BuyΔOwn +83.7%
2025-11-07
$100,793
|
||||||
| CAI |
Caris Life Sciences, Inc.
|
Officer • See Remarks
Discretionary BuyΔOwn +83.7%
|
2025-11-07 | $100,793 | P | Form 4 |
|
CAI
P
Caris Life Sciences, Inc.
Spetzler David Baxley
• President
Discretionary Buy
2025-11-07
$9,540
|
||||||
| CAI |
Caris Life Sciences, Inc.
|
President
Discretionary Buy
|
2025-11-07 | $9,540 | P | Form 4 |